[Clinical testing of the radiosensitizer RO-07-0582 (misonidazole). Dose tolerance, toxicity and pharmacokinetic studies, preliminary report (author's transl)].
D001859:Bone Neoplasms / Q000628:therapy; D002986:Clinical Trials as Topic; D005910:Glioma / Q000628:therapy; D006801:Humans; D007700:Kinetics; D008920:Misonidazole / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D009369:Neoplasms / Q000628:therapy; D009593:Nitroimidazoles / Q000627:therapeutic use*; D010038:Otorhinolaryngologic Diseases / Q000628:therapy; D012509:Sarcoma / Q000628:therapy
D009593:Nitroimidazoles; D008920:Misonidazole
Essai clinique du radiosensibilisant RO-07-0582 ou misonidazole: Tolérance et toxicité, étude pharmacocinétique, rapport préliminaire.